These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 6790561

  • 1. Absence of thyroid-stimulating antibody and long acting thyroid stimulator in relatives of Graves' disease patients.
    Banovac K, Zakarija M, McKenzie JM, Witte A, Sekso M.
    J Clin Endocrinol Metab; 1981 Sep; 53(3):651-3. PubMed ID: 6790561
    [Abstract] [Full Text] [Related]

  • 2. Effect of thyrotropin-releasing hormone on serum thyroid hormones: a study in the patients with untreated and treated Graves' disease and subacute thyroiditis.
    Sato A, Yamada T, Aizawa T, Ichikawa K, Komiya I, Takasu N, Takemura Y.
    J Clin Endocrinol Metab; 1995 Jul; 80(7):2173-7. PubMed ID: 7608274
    [Abstract] [Full Text] [Related]

  • 3. Comparison between thyroid stimulating and tsh-binding inhibiting immunoglobulins of Graves' disease.
    Macchia E, Fenzi GF, Monzani F, Lippi F, Vitti P, Grasso L, Bartalena L, Baschieri L, Pinchera A.
    Clin Endocrinol (Oxf); 1981 Aug; 15(2):175-82. PubMed ID: 6118213
    [Abstract] [Full Text] [Related]

  • 4. Thyroid response, especially to thyrotropin-binding inhibitory immunoglobulins, in euthyroid relatives of patients with Graves' disease: a clinical follow-up.
    Tamai H, Kasagi K, Morita T, Hidaka A, Kuma K, Konishi J, Kumagai LF, Nagataki S.
    J Clin Endocrinol Metab; 1990 Jul; 71(1):210-5. PubMed ID: 1973421
    [Abstract] [Full Text] [Related]

  • 5. Studies on thyrotrophin receptor antibodies in patients with euthyroid Graves' disease.
    Kasagi K, Hatabu H, Tokuda Y, Iida Y, Endo K, Konishi J.
    Clin Endocrinol (Oxf); 1988 Oct; 29(4):357-66. PubMed ID: 2908031
    [Abstract] [Full Text] [Related]

  • 6. Correlation of long-acting thyroid stimulator with serum levels of tri-iodothyronine, thyroxine and thyrotropin in Graves' disease.
    Sawhney RC, Kannan V, Rastogi GK.
    J Assoc Physicians India; 1975 Feb; 23(2):111-4. PubMed ID: 1242389
    [No Abstract] [Full Text] [Related]

  • 7. Low response of the thyroid gland to endogenous thyrotropin increased by thyrotropin-releasing hormone in patients with euthyroid Graves' disease.
    Kashiwai T, Tada H, Watanabe Y, Shimaoka Y, Yagoro A, Hidaka Y, Fujikado T, Amino N.
    Thyroid; 1998 Oct; 8(10):881-5. PubMed ID: 9827654
    [Abstract] [Full Text] [Related]

  • 8. [Studies on the radioreceptor assay of TSH: the properties of TSH-binding inhibitor immunoglobulins (TBII) in patients with Graves' disease (author's transl)].
    Endo K.
    Nihon Naibunpi Gakkai Zasshi; 1979 Oct 20; 55(10):1261-74. PubMed ID: 228998
    [Abstract] [Full Text] [Related]

  • 9. Role of thyrotropin receptor antibodies in the development of hyperthyroidism: follow-up studies on nine patients with Graves' disease.
    Kasagi K, Tamai H, Morita T, Hidaka A, Hatabu H, Misaki T, Iida Y, Ishihara T, Ikekubo K, Kuma K.
    J Clin Endocrinol Metab; 1989 Jun 20; 68(6):1189-94. PubMed ID: 2566620
    [Abstract] [Full Text] [Related]

  • 10. Significance of thyroid stimulating antibody and long term follow up in patients with euthyroid Graves' disease.
    Kashiwai T, Tada H, Asahi K, Hidaka Y, Tamaki H, Iwatani Y, Amino N.
    Endocr J; 1995 Jun 20; 42(3):405-12. PubMed ID: 7670570
    [Abstract] [Full Text] [Related]

  • 11. Abnormalities of hypothalamo-hypophyseal-thyroid axis in patients with Graves' ophthalmopathy.
    Chopra IJ, Chopra U, Orgiazzi J.
    J Clin Endocrinol Metab; 1973 Dec 20; 37(6):955-67. PubMed ID: 4201831
    [No Abstract] [Full Text] [Related]

  • 12. Detection and properties of TSH-binding inhibitor immunoglobulins in patients with Graves' disease and Hashimoto's thyroiditis.
    Endo K, Kasagi K, Konishi J, Ikekubo K, Okuno T, Takeda Y, Mori T, Torizuka K.
    J Clin Endocrinol Metab; 1978 May 20; 46(5):734-9. PubMed ID: 45421
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Human thyroid adenyl cyclase-stimulating activity in immunoglobulin G of patients with Graves' disease.
    Orgiazzi J, Williams DE, Chopra IJ, Solomon DH.
    J Clin Endocrinol Metab; 1976 Feb 20; 42(2):341-54. PubMed ID: 946604
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effect of methimazole with or without exogenous L-thyroxine on serum concentrations of thyrotropin (TSH) receptor antibodies in patients with Graves' disease.
    Rittmaster RS, Zwicker H, Abbott EC, Douglas R, Givner ML, Gupta MK, Lehmann L, Reddy S, Salisbury SR, Shlossberg AH, Tan MH, York SE.
    J Clin Endocrinol Metab; 1996 Sep 20; 81(9):3283-8. PubMed ID: 8784084
    [Abstract] [Full Text] [Related]

  • 19. [The relationship between serum thyroid autoantibodies, iodine intake, development and prognosis of Graves' disease].
    Chen W, Man N, Li YS, Shan ZY, Teng WP.
    Zhonghua Nei Ke Za Zhi; 2006 Feb 20; 45(2):95-9. PubMed ID: 16624113
    [Abstract] [Full Text] [Related]

  • 20. [Euthyroid exophthalmos: evaluation of 6 patients].
    Gheri RG, Borghi A, Pratesi E, Maiello M.
    Boll Soc Ital Biol Sper; 1983 May 30; 59(5):651-4. PubMed ID: 6136283
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.